Jonathan Creech, MD
Adult Reconstructive Orthopaedic Surgery · Fayetteville, ARNPI 1922495779
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 62.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $12,435 and has fallen 61.6% since, to $4,775 in 2025.
Across 62 payments — averaging $565.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$22K
- Zimmer Biomet$6K
- Canary Medical USA LLC$6K
- Stryker$668
- Kala Pharmaceuticals, Inc.$125
- Flower Orthopedics Coporation$63
- plus $227 from 10 others
What the payments were for
- Consulting fees$5,75016%
- Travel & lodging$5,70216%
- Food & beverage$3,44910%
- Education$20,15157%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 11 | $21,742 |
| Zimmer Biomet | 32 | $6,348 |
| Canary Medical USA LLC | 5 | $5,879 |
| Stryker | 2 | $668 |
| Kala Pharmaceuticals, Inc. | 1 | $125 |
| Flower Orthopedics Coporation | 1 | $63 |
| Innovation Technologies Inc | 1 | $38 |
| Globus Medical | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| AbbVie | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Radius Health, Inc. | 1 | $21 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| KCI USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$1,812
- ROSA$1,589
- Journey II$1,517
- CORI$1,365
- POLAR3$840
- Legion Revision$840
- MAKO$639
- BIRMINGHAM HIP$526
- KNEE3 Software$526
- Avenir$214
- Wagner Cone Prosthesis$143
- EYSUVIS$125
- TAPESTRY$106
How this compares
Too few adult reconstructive orthopaedic surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 549 | $2,962 |
| Celecoxib | 182 | $2,222 |
| Cefadroxil | 112 | $688 |
| Mupirocin | 89 | $537 |
| Meloxicam | 98 | $186 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $176 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $168 |
| Tramadol Hcl | 40 | $148 |
| Ondansetron Hcl | 29 | $132 |
| Methocarbamol | 15 | $120 |
| Ibuprofen | 12 | $61 |
| Amoxicillin | 55 | $50 |
| Clindamycin Hcl | 14 | $49 |
| Gabapentin | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Fayetteville
- Charles HanbyFayetteville$81K
- David CollinsLittle Rock$2.4M
- Paul EdwardsLittle Rock$158K
- Samuel BaxterLittle Rock$11K
- Jon BanwartBentonville$5K
- David NewbernLittle Rock$3K
- Adam NorwoodLittle Rock$1K
- Adam SmithLittle Rock$751
- Russell RaulsMountain Home$618
- Michael HusseyLittle Rock$436
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.